Convatec Group (FRA:2CV) FFO per Share


FRA:2CV Convatec Group PLC FRA:2CV
77 GF Score
Price €2.54
GF Value €2.98
! 4 Warning Signs
View Full Analysis

What is Convatec Group FFO per Share?

FFO per Share only applies to REITs.

FRA:2CV
77GF Score
Convatec Group PLC FRA:2CV
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (FRA:2CV) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €2.54 is trading 14.8% below its estimated GF Value™ of €2.98.

Key valuation signals for FRA:2CV:

  • FFO per Share:
  • GF Value™: €2.98 vs. price of €2.54 (14.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the FRA:2CV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for FRA:2CV

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.54
Price
€2.98
GF Value